146 related articles for article (PubMed ID: 12563133)
1. Kinetics of a US contrast agent in benign and malignant adnexal tumors.
Ordén MR; Jurvelin JS; Kirkinen PP
Radiology; 2003 Feb; 226(2):405-10. PubMed ID: 12563133
[TBL] [Abstract][Full Text] [Related]
2. Contrast-enhanced sonography in the examination of benign and malignant adnexal masses.
Ordén MR; Gudmundsson S; Kirkinen P
J Ultrasound Med; 2000 Nov; 19(11):783-8. PubMed ID: 11065267
[TBL] [Abstract][Full Text] [Related]
3. Differentiating between benign and malignant adnexal lesions with contrast-enhanced transvaginal ultrasonography.
Szymanski M; Socha MW; Kowalkowska ME; Zielińska IB; Eljaszewicz A; Szymanski W
Int J Gynaecol Obstet; 2015 Nov; 131(2):147-51. PubMed ID: 26254725
[TBL] [Abstract][Full Text] [Related]
4. Intravenous contrast ultrasound examination using contrast-tuned imaging (CnTI) and the contrast medium SonoVue for discrimination between benign and malignant adnexal masses with solid components.
Testa AC; Timmerman D; Van Belle V; Fruscella E; Van Holsbeke C; Savelli L; Ferrazzi E; Leone FP; Marret H; Tranquart F; Exacoustos C; Nazzaro G; Bokor D; Magri F; Van Huffel S; Ferrandina G; Valentin L
Ultrasound Obstet Gynecol; 2009 Dec; 34(6):699-710. PubMed ID: 19924735
[TBL] [Abstract][Full Text] [Related]
5. Contrast-enhanced sonography helps in discrimination of benign from malignant adnexal masses.
Marret H; Sauget S; Giraudeau B; Brewer M; Ranger-Moore J; Body G; Tranquart F
J Ultrasound Med; 2004 Dec; 23(12):1629-39; quiz 1641-42. PubMed ID: 15557306
[TBL] [Abstract][Full Text] [Related]
6. Power Doppler vascularity index for predicting malignancy of adnexal masses.
Marret H; Sauget S; Giraudeau B; Body G; Tranquart F
Ultrasound Obstet Gynecol; 2005 May; 25(5):508-13. PubMed ID: 15846763
[TBL] [Abstract][Full Text] [Related]
7. Effects of a microbubble contrast agent on breast tumors: computer-assisted quantitative assessment with color Doppler US--early experience.
Huber S; Helbich T; Kettenbach J; Dock W; Zuna I; Delorme S
Radiology; 1998 Aug; 208(2):485-9. PubMed ID: 9680580
[TBL] [Abstract][Full Text] [Related]
8. Value of contrast-enhanced power Doppler sonography using a microbubble echo-enhancing agent in evaluation of small breast lesions.
Kook SH; Kwag HJ
J Clin Ultrasound; 2003 Jun; 31(5):227-38. PubMed ID: 12767017
[TBL] [Abstract][Full Text] [Related]
9. Nonpalpable breast lesions: evaluation with power Doppler US and a microbubble contrast agent-initial experience.
Moon WK; Im JG; Noh DY; Han MC
Radiology; 2000 Oct; 217(1):240-6. PubMed ID: 11012451
[TBL] [Abstract][Full Text] [Related]
10. Adding a single CA 125 measurement to ultrasound imaging performed by an experienced examiner does not improve preoperative discrimination between benign and malignant adnexal masses.
Valentin L; Jurkovic D; Van Calster B; Testa A; Van Holsbeke C; Bourne T; Vergote I; Van Huffel S; Timmerman D
Ultrasound Obstet Gynecol; 2009 Sep; 34(3):345-54. PubMed ID: 19585547
[TBL] [Abstract][Full Text] [Related]
11. Doppler sonography of adnexal masses: the predictive value of the pulsatility index in benign and malignant disease.
Salem S; White LM; Lai J
AJR Am J Roentgenol; 1994 Nov; 163(5):1147-50. PubMed ID: 7976891
[TBL] [Abstract][Full Text] [Related]
12. Contrast-enhanced, three-dimensional power Doppler sonography for differentiation of adnexal masses.
Kupesic S; Kurjak A
Obstet Gynecol; 2000 Sep; 96(3):452-8. PubMed ID: 10960641
[TBL] [Abstract][Full Text] [Related]
13. Quantifying tumor vascular heterogeneity with DCE-MRI in complex adnexal masses: A preliminary study.
Thomassin-Naggara I; Soualhi N; Balvay D; Darai E; Cuenod CA
J Magn Reson Imaging; 2017 Dec; 46(6):1776-1785. PubMed ID: 28370815
[TBL] [Abstract][Full Text] [Related]
14. What do contrast media add to three-dimensional power Doppler evaluation of adnexal masses?
Sparac V; Kupesić S; Kurjak A
Croat Med J; 2000 Sep; 41(3):257-61. PubMed ID: 10962043
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of benign and malignant adnexal masses: relative value of gray-scale, color Doppler, and spectral Doppler sonography.
Stein SM; Laifer-Narin S; Johnson MB; Roman LD; Muderspach LI; Tyszka JM; Ralls PW
AJR Am J Roentgenol; 1995 Feb; 164(2):381-6. PubMed ID: 7839975
[TBL] [Abstract][Full Text] [Related]
16. Prospective cross-validation of Doppler ultrasound examination and gray-scale ultrasound imaging for discrimination of benign and malignant pelvic masses.
Valentin L
Ultrasound Obstet Gynecol; 1999 Oct; 14(4):273-83. PubMed ID: 10586480
[TBL] [Abstract][Full Text] [Related]
17. [The use of 2-dimensional and 3-dimensional color and power-Doppler in the diagnosis of blood flow indices of adnexal tumors].
Czekierdowski A; Stachowicz N; Smoleń A; Kotarski J
Ginekol Pol; 2006 Apr; 77(4):296-306. PubMed ID: 16875035
[TBL] [Abstract][Full Text] [Related]
18. Ultrasonographic contrast agent: evaluation of time-intensity curves in the characterisation of solitary thyroid nodules.
Argalia G; De Bernardis S; Mariani D; Abbattista T; Taccaliti A; Ricciardelli L; Faragona S; Gusella PM; Giuseppetti GM
Radiol Med; 2002 Apr; 103(4):407-13. PubMed ID: 12107391
[TBL] [Abstract][Full Text] [Related]
19. Discrimination between benign and malignant adnexal masses by specialist ultrasound examination versus serum CA-125.
Van Calster B; Timmerman D; Bourne T; Testa AC; Van Holsbeke C; Domali E; Jurkovic D; Neven P; Van Huffel S; Valentin L
J Natl Cancer Inst; 2007 Nov; 99(22):1706-14. PubMed ID: 18000221
[TBL] [Abstract][Full Text] [Related]
20. Intra- and interobserver variability of 2D and 3D transvaginal sonography in the diagnosis of benign versus malignant adnexal masses.
Pascual MA; Graupera B; Hereter L; Rotili A; Rodriguez I; Alcázar JL
J Clin Ultrasound; 2011 Jul; 39(6):316-21. PubMed ID: 21500198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
